Terms: = Colorectal cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT AND Prognosis
5 results:
1. DNA Mutational Profiling in Patients With colorectal cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
Innocenti F; Mu W; Qu X; Ou FS; Kabbarah O; Blanke CD; Venook AP; Lenz HJ; Rashid NU
J Clin Oncol; 2024 Feb; 42(4):399-409. PubMed ID: 37992266
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
3. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of genomic alterations in Chinese colorectal cancer patients.
Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
[TBL] [Abstract] [Full Text] [Related]
5. High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Ge W; Hu H; Cai W; Xu J; Hu W; Weng X; Qin X; Huang Y; Han W; Hu Y; Yu J; Zhang W; Ye S; Qi L; Huang P; Chen L; Ding K; Wang LD; Zheng S
Int J Cancer; 2020 Apr; 146(7):2027-2035. PubMed ID: 31693169
[TBL] [Abstract] [Full Text] [Related]
